EUVIMEDEUVIMED entdecken
Crossref

Pancreatic enzyme replacement therapy for exocrine pancreatic insufficiency—Insights into prescribing practices

Sudipta Dhar Chowdhury, Soumya Jagannath Mahapatra, Reuben Thomas Kurien, Ajith Thomas, Gauri Kumbhar, Pramod Kumar Garg

Indian Journal of Gastroenterology · 17.08.2026

DOI: 10.1007/s12664-026-02046-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Gastroenterology, online erschienen am 17.08.2026. Verfasst von Sudipta Dhar Chowdhury und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Christian Medical College Vellore, Vellore, 632 004, India. sudiptadharchowdhury@gmail.com. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Exocrine pancreatic insufficiency (EPI) can affect individuals with a wide range of diseases. Despite the publication of multiple international guidelines, the prescribing practices vary across the globe. The present study was done with an aim to assess how doctors in India evaluate and manage EPI, focusing on usage of pancreatic exocrine replacement therapy (PERT) and barriers to its use. METHODS: This was a cross-sectional questionnaire-based survey using Google forms. Doctors practicing gastroenterology were invited using email, social media networks to participate voluntarily. Trainees were excluded to ensure that the responses reflected independent clinical practice. The questionnaire was designed to assess the following domains: evaluation of EPI, use of PERT, response to therapy, strategies for non-response and perceived barriers to therapy. RESULTS: Total 586 doctors were approached for the questionnaire survey between May 2023 and January 2024. Responses were received from 520 doctors, eight were excluded as they were still in training. Among the doctors most were gastroenterologists, in private practice with a mean age of 42.2 (SD 9.4) years. Fecal elastase-1 appeared to be the most popular test for testing EPI. The most common indication for starting PERT was symptomatic EPI. Approximately 50% of doctors reported prescribing PERT in the setting of AP. The most common indication for PERT in acute pancreatitis was acute necrotizing pancreatitis (ANP). Most doctors prescribed 25,000 lipase units with each major meal and 10,000 units with snacks. Cost of therapy appeared as the biggest limitation for therapy with PERT. A majority (86.1%) of doctors were assessed for response, relying primarily on clinical indicators. Non-response is managed by dose increase and adjunctive therapies. DISCUSSION: This large questionnaire-based survey conducted across India suggests that while the management of EPI generally aligns with published international guidelines, there is a pressing need for India-specific recommendations, particularly to address cost-related barriers that impact access to PERT.

Schlagwörter

Stichwörter der Autor:innen

Acute pancreatitisChronic pancreatitisElastaseExocrine pancreatic insufficiencyPancreatic enzyme replacement therapyPancreatitisPancrelipase

Autor:innen und Institutionen

  • Department of Gastroenterology, Christian Medical College Vellore, Vellore, 632 004, India. sudiptadharchowdhury@gmail.com.
  • Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110 029, India.
  • Department of Gastroenterology, Christian Medical College Vellore, Vellore, 632 004, India.

Zitieren

APA

Dhar Chowdhury, S., Mahapatra, S. J., Kurien, R. T., Thomas, A., Kumbhar, G., & Garg, P. K. (2026). Pancreatic enzyme replacement therapy for exocrine pancreatic insufficiency—Insights into prescribing practices. Indian Journal of Gastroenterology. https://doi.org/10.1007/s12664-026-02046-9

Vancouver

Dhar Chowdhury S, Mahapatra SJ, Kurien RT, Thomas A, Kumbhar G, Garg PK. Pancreatic enzyme replacement therapy for exocrine pancreatic insufficiency—Insights into prescribing practices. Indian Journal of Gastroenterology. 2026. doi:10.1007/s12664-026-02046-9

BibTeX
@article{DharChowdhury2026,
  author = {Dhar Chowdhury, Sudipta and Mahapatra, Soumya Jagannath and Kurien, Reuben Thomas and Thomas, Ajith and Kumbhar, Gauri and Garg, Pramod Kumar},
  title = {Pancreatic enzyme replacement therapy for exocrine pancreatic insufficiency—Insights into prescribing practices},
  journal = {Indian Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s12664-026-02046-9}
}
Kostenlos starten →